Tag: antiasthma
AstraZeneca: the PADAC shared on the anti-asthma inhaler
(CercleFinance.com) – AstraZeneca announces that the Food and Drug Administration’s (FDA) Pulmonary Allergy Drug Advisory Committee (PADAC) has issued a favorable evaluation (16 votes against 1) on the risk/benefit ratio…